Brief: Salarius Pharmaceuticals Reports Third Quarter Results

Decoy Therapeutics

10/11/2022 16:30

Nov 10 (Reuters) - Salarius Pharmaceuticals Inc
 SLRX.O :
    * SALARIUS PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * NET LOSS FOR Q3 OF 2022 WAS $14.4 MILLION, OR $6.41 PER
SHARE

Source text for Eikon:  ID:nGNX69x0Ng 
Further company coverage:  SLRX.O 
 ((reuters.briefs@thomsonreuters.com;))